SFDA sets limit standard for residual sulphur dioxide in Chinese crude drugs and prepared slices of Chinese crude drugs

In order to prevent abuse or excessive usage of sulphur fumigation in the primary processing of Chinese crude drugs and ensure the quality, safety and effectiveness of traditional Chinese medicines, t

Phexcom Pharma Excipients&Drug Preparation Technical Service(Guangzhou) Centre was set up

Phexcom Pharma Excipients&Drug Preparation Technical Service(Guangzhou) Centre was set up in Haizhu Science Park on 3 June,2011. The centre provides technical exchange platform for Pharma excipien

Breckenridge receives final FDA approval for Letrozole ANDA

Breckenridge Pharmaceutical, Inc. announced today the immediate launch of Letrozole 2.5 mg Tablets. The U.S. Food and Drug Administration granted final approval for the Abbreviated New Drug Applic

Larger trial study needed to decide fate of niacinNiaspan is a cholesterol drug manufactured by Abbott Laboratories. Doctors have customarily prescribed Niacin to raise levels of HDL ("good" cholesterol) in patients taking a statin pill that is successfully lowering their LDL ("bad" cholesterol). Yet this practice is now being questioned after a National Institutes of Health study released in late May, called AIM-HIGH, showed that Niaspan failed to prevent heart attacks and slightly raised the risk of a stroke when combined with the cholesterol drug Zocor (simvastatin).

Niaspan is a cholesterol drug manufactured by Abbott Laboratories. Doctors have customarily prescribed Niacin to raise levels of HDL ("good" cholesterol) in patients taking a statin pill that is succe

Merck announces changes to high-dose simvastatin prescribing information in the U.S.

Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced changes to the prescribing information in the United States for the highest dose of simvastatin, 80 mg, and the use

Respira introduces breakthrough Dry Powder Inhaler

Respira Therapeutics, a product development company focused on inhaled therapeutics to improve patients' lives, introduces the company's Dry Powder Inhaler (DPI) as a breakthrough solution for the pha

Moody's Predicts Downturn for the Pharma Industry

Global credit rating agency Moody's has predicted a negative outlook for the pharmaceutical industry as a number of patents are due to expire, increasing pressure on large drug companies. Moody's b

SFDA issues the No.148 announcement of drug administrative protection

The State Food and Drug Administration (SFDA) issued the No.148 Drug Administrative Protection Announcement on June 2, 2011, declaring the ending of drug administrative protection for Bracco S.P.A.’s

Bayer HealthCare seeks EU marketing authorization of VEGF Trap-Eye for treatment of wet AMD

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Bayer HealthCare today announced that Bayer HealthCare has submitted an application for marketing authorization in Europe for VEGF Trap-Eye for the t

FDA grants orphan drug designation for Aradigm's ciprofloxacin to manage bronchiectasis

Aradigm Corporation (OTCBB:ARDM) (the "Company") today announced it has received orphan drug designation from the U.S. Food and Drug Administration (FDA) for ciprofloxacin for inhalation for the manag